Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,272,704 papers from all fields of science
Search
Sign In
Create Free Account
CEM 101
Known as:
CEM-101
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Macrolides
Triazoles
Solithromycin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Antimicrobial Activity of Solithromycin (CEM-101), a Novel Fluoroketolide, Tested Against Isolates Collected in Europe during 2010 Surveillance
D. Biedenbach
,
H. Sader
,
R. Jones
,
D. Farrell
2011
Corpus ID: 74623793
1136 DJ Biedenbach1, HS Sader1, RN Jones1, DJ Farrell1 1JMI Laboratories, North Liberty, Iowa, USA Objective: To evaluate the…
Expand
2008
2008
Antimicrobial Characterization of CEM-101: PAE, Bactericidal Activity and Combinations
Ronald N. Jones
2008
Corpus ID: 87858376
MBC determinations for CEM-101, telithromycin (TEL) and clarithromycin (CLA) used CLSI methods for 40 strains (6 species groups…
Expand
2008
2008
Antimicrobial Characterization of CEM-101 Activity Against 331 Respiratory Tract Pathogens Including Multidrug-Resistant Pneumococcal Serogroup 19A (MDR-19A) Isolates
Ronald N. Jones
2008
Corpus ID: 87531920
A worldwide sample of organisms included S. pneumoniae (SPN; 168, 59.3% erythromycin [ERY]-R and 18 MDR-19A strains), M…
Expand
2008
2008
Binding and Action of CEM-101, A New Macrolide/Ketolide in Development for Treating Infections with Macrolide-Resistant and Macrolide-Susceptible Bacteria
Beatriz Llano-Sotelo
2008
Corpus ID: 88116528
CEM-101 displayed a tight binding to the ribosome from sensitive Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria…
Expand
2008
2008
Antimicrobial Characterization of CEM-101: Activity Against Enterococci, Uncommon Gram-positive Pathogens, N. gonorrhoeae and Anaerobes
D. Biedenbach
,
T. Fritsche
,
H. Sader
2008
Corpus ID: 97341111
Results: CEM-101 potency against enterococci showed a bimodal distribution (0.03 and 2 μg/ml), and that activity was 2and ≥ 32…
Expand
2008
2008
Evaluation of CEM-101, a Novel Macrolide, in Murine Infection Models
Timothy M. Murphy
2008
Corpus ID: 87536808
Efficacy was evaluated in several infection models. CD-1 female mice were infected IP; CEM-101 or comparators were administered…
Expand
2008
2008
Antimicrobial Characterization of CEM-101: Single Step, Selection by Passaging and Inducible Resistances
Ronald N. Jones
2008
Corpus ID: 85810427
Background: CEM-101, an orally administered macrolide-ketolide for respiratory tract infections (RTI), has potent activity…
Expand
2008
2008
Single Oral Dose Pharmacokinetics and Safety of CEM-101 in Healthy Subjects
J. Still
2008
Corpus ID: 74822903
Poster # F1-3972a Study Design and Methodology Results J. Gordon Still, MD, PhD 6340 Quadrangle Dr., Suite 100 Chapel Hill, NC…
Expand
2008
2008
Antimicrobial Activity of CEM-101 a New Macrolide, Tested Against Diverse Collections of Bacterial Biowarfare/Bioterrorism(BW/BT) Agents
H. Heine
2008
Corpus ID: 22328062
There continues to be a feared scenario of terrorist attacks with aerosolized microorganisms leading to mass infections. Given…
Expand
2008
2008
Proposed MIC Quality Control Ranges for CEM-101 Using the CLSI Multi-Laboratory M23-A2 Study Design
P. Rhomberg
2008
Corpus ID: 61846454
CEM-101 is a promising new macrolide in development for treating community-acquired (CA) macrolide-resistant and -susceptible…
Expand